 forming a five– or six-membered ring connected with the benzene ring in ortho position; whether or not further modified in one or more of the following ways: • by substuitution of one or both hydrogen atoms of amino group; • by replacing of hydrogen atom at carbon atom next to amino group with an alkyl group. cikloheksilfenoli Cyclohexylphenols Spojevi strukturno izvedeni iz 2-(3-hidroksicikoheksil)fenola supstitucijom na položaju 5 fenolnog prstena alkilnom, halogenalkilnom, alkenilnom, cikloalkilmetilnom, cikloalkiletilnom, 1-(N-metil-2-piperidinil)metilnom ili 2-(4-morfolinil)etilnom skupinom, bez obzira na to jesu li ili nisu dodatno supsitituirani na cikloheksanskom prstenu. Compounds structurally derived from 2-(3-hydroxycyclohexyl)phenol by substitution at the 5-position of the phenolic ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the cyclohexane ring. dibenzopirani dibenzopyranes Spojevi strukturno izvedeni iz kanabinola (izuzev kanabidiola) hidrirani na prstenu A, bez obzira na to jesu li ili nisu dodatno supstituirani na prstenu B; homolozi navedenih spojeva s različitim brojem ugljikovih atoma u supstituentu na položaju 3, njihovi stereoizomeri, te derivati navedenih spojeva izvedeni supstitucijom na hidroksilnoj skupini. Compounds structurally derived from cannabinol (except cannabidiol) hydrated on the ring A, whether or not additionaly substrituted on the ring B; their homologues with different number of carbon atoms in the substituent in 3-position, their stereoisomers, as well as their derivatives by substitution at hydroxyl group. 4,4’-dimetilaminoreks (4,4’-DMAR) 4,4’-dimethylaminorex (4,4’-DMAR) 4,5-dihidro-4-metil-5-(4-metilfenil)-2-oksazolamin 4,5-dihydro-4-methyl-5-(4-methylphenyl)-2-oxazolamine 2,5-dimetoksifeniletanamini 2,5-dimethoxyphenylethanamines 2-(2,5-dimetoksifenil)etanamin i spojevi strukturno izvedeni iz 2-(2,5-dimetoksifenil)etanamina supstitucijom na benzenskom prstenu s jednim ili više supstituenata iz skupine koju čine alkil, halogenalkil, alkiloksi, halogenalkiloksi, alkiltio, halogenalkiltio, halogen i nitro, bez obzira na to jesu ili nisu dodatno modificirani na jedan ili više od sljedećih načina: • zamjenom jednog ili više vodikovih atoma etilenske skupine s jednom ili više alkilnih skupina; • zamjenom jednog ili oba vodikova atoma amino-skupine alkilnom, halogenalkilnom, hidroksilnom, hidroksialkilnom, benzilnom ili supstituiranom benzilnom skupinom. 2-(2,5-dimethoxyphenyl)ethanamine, and compounds structurally derived from 2-(2,5-dimethoxyphenyl)ethanamine by substitution in the benzene ring with one or more substituents from the group consisting of alkyl, haloalkyl, alkoxy, alkylthio, haloalkylthio, halogen and nitro, whether or not further modified in one or more of the following ways: • by replacing one or more hydrogen atoms of the ethylene group with one or more alkyl groups; • by replacing one or both hydrogen atoms of amino group with an alkyl, haloalkyl, hydroxy, hydroxyalkyl, benzyl or substituted benzyl group. eticiklidin Eticyclidine N-etil-1-fenilcikloheksilamin N-ethyl-1-phenylcyclohexylamine etilfenidat Ethylphenidate etil-2-fenil-2-(piperidin-2-il)acetat ethyl 2-phenyl-2-(piperidin-2-yl)acetate etriptamin Etryptamine 3-(2-aminobutil)indol 3-(2-aminobutyl)indole fenazepam phenazepam 7-brom-5-(2-klorfenil)-1,3-dihidro-2H-1,4-benzodiazepin-2-on 7-bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one homoamfetamin homoamphetamine 3-amino-1-fenilbutan 3-amino-1-phenylbutane iboga (Tabernanthe iboga) Iboga (Tabernanthe iboga)     ibogain Ibogaine 12-metoksiibogamin 12-Methoxyibogamine JWH-018 i njegovi strukturni analozi JWH-018 and its structural analogues 1-pentil-3-(1-naftoil)indol (JWH-018) i spojevi strukturno izvedeni iz njega na jedan ili više od sljedećih načina: • zamjenom indolske osnove indanom, indenom, indazolom, pirolom,